Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -283.95%-63.02K | -123.91%-4.47K | 27.81%-23.52K | 56.97%-76.78K | -5.34%-46.5K | 76.64%-16.41K | 429.75%18.71K | 44.17%-32.58K | 26.65%-178.45K | 67.99%-44.14K |
| Net income from continuing operations | -1,286.83%-37.5K | -404.21%-13.88K | 1,032.37%226.05K | 42.97%-95.09K | -29.66%-72.7K | 92.78%-2.7K | 111.66%4.56K | 28.87%-24.25K | 60.52%-166.72K | 6.42%-56.07K |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --7.43K | ---- |
| Remuneration paid in stock | 53.25%2.78K | 21.35%4.48K | 38.34%6.72K | -14.73%22.23K | 57.48%11.86K | -20.72%1.81K | -44.95%3.7K | -49.06%4.86K | -66.56%26.06K | -54.76%7.53K |
| Other non cashItems | ---4 | --5 | ---250.05K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -82.28%-28.3K | -53.01%4.91K | 52.72%-6.24K | 91.34%-3.92K | 573.47%14.35K | 55.80%-15.52K | -60.90%10.45K | 60.97%-13.19K | -144.74%-45.22K | 96.80%-3.03K |
| -Change in receivables | ---1.23K | -101.97%-41 | 112.91%113 | -92.69%869 | -147.39%-336 | --0 | -84.28%2.08K | 40.15%-875 | 219.88%11.88K | 174.24%709 |
| -Change in prepaid assets | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -24.78%853 | ---- |
| -Change in payables and accrued expense | -58.26%-24.57K | -40.85%4.95K | 48.45%-6.35K | 91.74%-4.79K | 419.73%14.68K | 55.82%-15.52K | -40.69%8.37K | 61.91%-12.32K | -152.76%-57.96K | 95.15%-4.59K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -283.95%-63.02K | -123.91%-4.47K | 27.81%-23.52K | 56.97%-76.78K | -5.34%-46.5K | 76.64%-16.41K | 429.75%18.71K | 44.17%-32.58K | 26.65%-178.45K | 67.99%-44.14K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 50.84%-1.32K | -4,985.19%-1.32K | 0 | 63.38%-2.68K | 27 | |||||
| Net PPE purchase and sale | ---- | ---- | ---- | 50.84%-1.32K | -4,985.19%-1.32K | --0 | ---- | ---- | 63.38%-2.68K | --27 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | 50.84%-1.32K | -4,985.19%-1.32K | --0 | ---- | ---- | 63.38%-2.68K | --27 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 81.2K | -50.15%72.53K | 156.49%72.53K | 0 | -27.25%145.5K | -85.86%28.28K | ||||
| Net common stock issuance | ---- | ---- | ---- | -50.15%72.53K | 156.49%72.53K | ---- | ---- | ---- | -27.25%145.5K | -85.86%28.28K |
| Proceeds from stock option exercised by employees | --81.2K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --81.2K | ---- | ---- | -50.15%72.53K | 156.49%72.53K | --0 | ---- | ---- | -27.25%145.5K | -85.86%28.28K |
| Net cash flow | ||||||||||
| Beginning cash position | -84.82%3.2K | 146.64%5.88K | -15.92%29.4K | -50.47%34.97K | -90.79%4.68K | -30.28%21.09K | -80.53%2.38K | -50.47%34.97K | -41.76%70.6K | 497.21%50.8K |
| Current changes in cash | 210.75%18.18K | -114.29%-2.67K | 27.81%-23.52K | 84.37%-5.57K | 256.11%24.72K | -179.96%-16.41K | 3.74%18.71K | 44.17%-32.58K | 29.61%-35.63K | -125.50%-15.83K |
| End cash Position | 357.03%21.38K | -84.82%3.2K | 146.64%5.88K | -15.92%29.4K | -15.92%29.4K | -90.79%4.68K | -30.28%21.09K | -80.53%2.38K | -50.47%34.97K | -50.47%34.97K |
| Free cash from | -283.95%-63.02K | -123.91%-4.47K | 27.81%-23.52K | 56.88%-78.1K | -8.39%-47.81K | 77.42%-16.41K | 413.66%18.71K | 44.17%-32.58K | 27.73%-181.13K | 68.01%-44.11K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.